BioMarin Pharmaceutical Inc
SWB:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioMarin Pharmaceutical Inc
SWB:BM8
|
US |
|
Evolus Inc
NASDAQ:EOLS
|
US |
|
ING Groep NV
LSE:0A2K
|
NL |
|
P
|
Panasonic Holdings Corp
SWB:MAT1
|
JP |
|
Standard Chartered PLC
LSE:STAN
|
UK |
|
C
|
Carnival Corp
LSE:0EV1
|
US |
|
Shanghai Jinjiang Shipping Group Co Ltd
SSE:601083
|
CN |
|
M
|
Marriott International Inc
F:MAQ
|
US |
|
S
|
Stockland Corporation Ltd
F:LN1
|
AU |
|
A
|
AstraZeneca PLC
XHAM:ZEG
|
UK |
|
K
|
Konami Group Corp
SWB:KOA
|
JP |
|
C
|
CSL Ltd
XMUN:CSJ
|
AU |
|
Woodside Energy Group Ltd
ASX:WDS
|
AU |
|
A
|
Amgen Inc
DUS:AMG
|
US |
|
A
|
AZZ Inc
F:AI7
|
US |
|
L
|
Lonza Group AG
DUS:LO3
|
CH |
|
T
|
TUI AG
F:TUI1
|
DE |
|
A
|
Alcoa Corp
XETRA:185
|
US |
|
Orthofix Medical Inc
F:OM2
|
US |
|
S
|
Standard Chartered PLC
OTC:SCBFY
|
UK |
|
Maxlinear Inc
F:JMX
|
US |
|
C
|
Continental AG
F:CON
|
DE |
|
U
|
UBS Group AG
BMV:UBSN
|
CH |
|
Stellantis NV
F:8TI
|
NL |
Bankruptcy Probability
BioMarin Pharmaceutical Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioMarin Pharmaceutical Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
BioMarin Pharmaceutical Inc
NASDAQ:BMRN
|
11.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
462.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
228B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
76.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioMarin Pharmaceutical Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioMarin Pharmaceutical Inc has total debt of 3.5B USD. This includes both short-term (0 USD) and long-term (3.5B USD) debt.
You can find a full breakdown on its Balance Sheet.